Multi-Target Neuroprotective Compound Exhibits EAAT2-Modulating and Alzheimer's Pathology-Attenuating Effects in In Vitro and In Vivo Models.
Overview
- Department of Medical Pharmacology, Faculty of Medicine, Atatürk University, 25240 Erzurum, Turkey
- Department of Chemistry, Faculty of Sciences, Atatürk University, 25240 Erzurum, Turkey
- Biotechnology Institute, Ankara University, 06135 Ankara, Turkey
- Trustlife Laboratories Drug Research & Development Center, 34774 İstanbul, Turkey
- Biochemistry Department, Faculty of Pharmacy, Istanbul Health and Technology University, Sütlüce, Beyoğlu, 34275 İstanbul, Turkey
- Faculty of Veterinary Medicine, Department of Pathology, Cumhuriyet University, 58140 Sivas, Turkey
- Department of Eye Diseases, Faculty of Medicine, Atatürk University, 25240 Erzurum, Turkey
- Department of Medical Pharmacology, Faculty of Medicine, Bilecik Seyh Edebali University, 11230 Bilecik, Turkey
- Department of Medical Biology, Faculty of Medicine, Atatürk University, 25240 Erzurum, Turkey
Abstract
Alzheimer’s disease (AD) is a debilitating neurodegenerative disorder characterized by cognitive decline and memory loss. Current treatments offer limited efficacy, necessitating the development of innovative multitarget therapeutic strategies. Here, we present N 3,N 5-bis(2-(5-methoxy-1H-i
Reproduced under the paper's license (CC BY), from the paper cited above.
Code
The paper links to its data and to no code of its authors: see the Data section.
Tracing map
A tracing map links a paper to the code its authors published: this paper has none, so it has no map.
Data
Datasets cited
- rcsb.org/
structure/ , at PDB; found in the text, “Molecular Docking (MD)”7xr4
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 1, 30 September 2026: the first record
Recorded: type, language, journal, volume, issue, pages, dates, 19 authors, 5 keywords, 15 MeSH terms, 94 references.
Cite
This paper
Hacımüftüoğlu, A., Saraçoğlu, N., Saffour, S., Abad, N., Kesgun, Y., Zegheb, N., Gundeger, E., Yeşilyurt, F., Ataş, M. N., Bati-Ayaz, G., Altunlu, Ö., Çınar, B., Yörük, M. A., Okkay, U., Özkaraca, M., Ateş, O., Taghizadehghalehjoughi, A., Lafzi, F., & Türkez, H. (2026). Multi-Target Neuroprotective Compound Exhibits EAAT2-Modulating and Alzheimer's Pathology-Attenuating Effects in In Vitro and In Vivo Models. ACS chemical neuroscience, 17(10), 1919-1944. https://
BibTeX
@article{hacmuftuoglu202
author = {Hacımüftüoğlu, Ahmet and Saraçoğlu, Nurullah and Saffour, Sana and Abad, Nadeem and Kesgun, Yunus and Zegheb, Nadjiba and Gundeger, Ersin and Yeşilyurt, Fatma and Ataş, Merve Nur and Bati-Ayaz, Gizem and Altunlu, Öznur and Çınar, Burak and Yörük, Mehmet Ali and Okkay, Ufuk and Özkaraca, Mustafa and Ateş, Orhan and Taghizadehghalehjoughi, Ali and Lafzi, Ferruh and Türkez, Hasan},
title = {{Multi-Target Neuroprotective Compound Exhibits EAAT2-Modulating and Alzheimer's Pathology-Attenuating Effects in In Vitro and In Vivo Models}},
journal = {ACS chemical neuroscience},
year = {2026},
month = apr,
volume = {17},
number = {10},
pages = {1919--1944},
publisher = {American Chemical Society},
issn = {1948-7193},
doi = {10.1021/
url = {https://
pmid = {42051019},
pmcid = {PMC13195668}
}
RIS
TY - JOUR
AU - Hacımüftüoğlu, Ahmet
AU - Saraçoğlu, Nurullah
AU - Saffour, Sana
AU - Abad, Nadeem
AU - Kesgun, Yunus
AU - Zegheb, Nadjiba
AU - Gundeger, Ersin
AU - Yeşilyurt, Fatma
AU - Ataş, Merve Nur
AU - Bati-Ayaz, Gizem
AU - Altunlu, Öznur
AU - Çınar, Burak
AU - Yörük, Mehmet Ali
AU - Okkay, Ufuk
AU - Özkaraca, Mustafa
AU - Ateş, Orhan
AU - Taghizadehghalehjoughi, Ali
AU - Lafzi, Ferruh
AU - Türkez, Hasan
TI - Multi-Target Neuroprotective Compound Exhibits EAAT2-Modulating and Alzheimer's Pathology-Attenuating Effects in In Vitro and In Vivo Models
T2 - ACS chemical neuroscience
J2 - ACS Chem Neurosci
PY - 2026
DA - 2026/
VL - 17
IS - 10
SP - 1919
EP - 1944
SN - 1948-7193
PB - American Chemical Society
DO - 10.1021/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.1021/
"type": "article-journal",
"title": "Multi-Target Neuroprotective Compound Exhibits EAAT2-Modulating and Alzheimer's Pathology-Attenuating Effects in In Vitro and In Vivo Models",
"container-title": "ACS chemical neuroscience",
"author": [
{
"family": "Hacımüftüoğlu",
"given": "Ahmet"
},
{
"family": "Saraçoğlu",
"given": "Nurullah"
},
{
"family": "Saffour",
"given": "Sana"
},
{
"family": "Abad",
"given": "Nadeem"
},
{
"family": "Kesgun",
"given": "Yunus"
},
{
"family": "Zegheb",
"given": "Nadjiba"
},
{
"family": "Gundeger",
"given": "Ersin"
},
{
"family": "Yeşilyurt",
"given": "Fatma"
},
{
"family": "Ataş",
"given": "Merve Nur"
},
{
"family": "Bati-Ayaz",
"given": "Gizem"
},
{
"family": "Altunlu",
"given": "Öznur"
},
{
"family": "Çınar",
"given": "Burak"
},
{
"family": "Yörük",
"given": "Mehmet Ali"
},
{
"family": "Okkay",
"given": "Ufuk"
},
{
"family": "Özkaraca",
"given": "Mustafa"
},
{
"family": "Ateş",
"given": "Orhan"
},
{
"family": "Taghizadehghalehjoughi"
"given": "Ali"
},
{
"family": "Lafzi",
"given": "Ferruh"
},
{
"family": "Türkez",
"given": "Hasan"
}
],
"container-title-short":
"volume": "17",
"issue": "10",
"page": "1919-1944",
"DOI": "10.1021/
"PMID": "42051019",
"PMCID": "PMC13195668",
"ISSN": "1948-7193",
"publisher": "American Chemical Society",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
4,
29
]
]
}
}
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.1021/acs.jmedchem.2c01572
- A Medicinal Chemistry Perspective on Excitatory Amino Acid Transporter 2 Dysfunction in Neurodegenerative Diseases.Journal: Journal of medicinal chemistryIn common: rcsb.org/structure/7xr4, 7 references
- [2] doi:10.3390/ph18020233
- Design, Synthesis, and Computational Evaluation of 3,4-Dihydroquinolin-2(<i
>1H</ i>)-One Analogues as Potential VEGFR2 Inhibitors in Glioblastoma Multiforme. Journal: Pharmaceuticals (Basel, Switzerland)In common: author Nadeem Abad - [3] doi:10.12688/f1000research.145391.3
- Molecular docking studies and molecular dynamic simulation analysis: To identify novel ATP-competitive inhibition of Glycogen synthase kinase-3β for Alzheimer's disease.Journal: F1000ResearchIn common: Alzheimer's / dementia, 3 references
- [4] doi:10.1021/acs.jcim.6c01299 [code]
- Targeting BCL-2 through Deep Learning-Based Drug Repurposing: A Multimodal Approach Combining Diffusion-Based Generative Modeling, Neural Relational Inference, and In Vitro Validation.Journal: Journal of chemical information and modelingIn common: cellular / molecular, 3 references
- [5] doi:10.1038/s41467-022-31031-x
- Structural basis of ligand binding modes of human EAAT2.Journal: Nature communicationsIn common: cellular / molecular, 3 references
- [6] doi:10.1038/s41380-022-01470-5
- Lifespan extension with preservation of hippocampal function in aged system x<sub>c</
sub><sup>-</ sup>-deficient male mice. Journal: Molecular psychiatryIn common: 3 references - [7] doi:10.1038/s44318-025-00498-x
- Optochemical profiling of NMDAR molecular diversity at synaptic and extrasynaptic sites.Journal: The EMBO journalIn common: cellular / molecular, 3 references
- [8] doi:10.1002/advs.202500402
- Pigment Epithelium-Derived Factor Deficiency Impairs Hippocampal Glutamate Homeostasis and Cognitive Function by Downregulating Astrocytic GLT-1.Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)In common: Alzheimer's / dementia, cellular / molecular, 2 references
- [9] doi:10.3389/fphar.2025.1650534
- Kaixin San Jiawei granule improves cognitive function and alleviates neuronal damage in Alzheimer's disease via multi-component and multi-target mechanisms.Journal: Frontiers in pharmacologyIn common: rat, Alzheimer's / dementia, 2 references
- [10] doi:10.1016/j.jbc.2024.107172
- Identification of PS1/
gamma-secretase and glutamate transporter GLT-1 interaction sites. Journal: The Journal of biological chemistryIn common: Alzheimer's / dementia, cellular / molecular, 2 references
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.
Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
